The promising results of a phase 1 clinical trial for the immunotherapy approach also showed that seven other women had no measurable disease at the end of the trial, the researchers added.
Their results are scheduled to be presented Saturday at the American Association for Cancer Research's annual meeting in Washington, D.C.
Ovarian cancer is fairly rare -- an estimated 1.38 percent of females born today will be diagnosed with the condition -- but it's an especially deadly form of cancer because it is usually diagnosed in an advanced stage.
The new treatment uses a personalized vaccine to try to teach the body's immune system how to fight off tumors.
More than 200 million eggs are being recalled over fears of salmonella.
Rose Acre Farms of Seymour,...
Researchers in Germany have developed a blood test for Alzheimer's that detects the disease several years...
The Arizona state House of Representatives passed a bill that would require women seeking abortions to...
Omni Healthcare is suing wholesale drug distributor McKesson Corp. on behalf of the federal government and...
